United Kingdom· GB-APID-42575411000001106
Tepkinly 4mg/0.8 ml concentrate for solution for injection vials
A epcoritamab product containing epcoritamab, registered in United Kingdom by AbbVie Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Epcoritamab is registered in 14 of 19 countries.
Countries holding a registration under ATC L01FX27 (epcoritamab), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Epcoritamab · ATC L01FX27
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of epcoritamab costs, country by country.
Normalised to the WHO defined daily dose (1.7 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Epcoritamab · price per daily dose (1.7 mg)
USD · FX 28 Sept 2026
- CH Switzerland$281.38
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Epcoritamab
- Manufacturer
- AbbVie Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01FX27
- ATC class
- Epcoritamab
- Defined daily dose
- 1.7 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin08054083026367
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Epcoritamab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesEPKINLYGenmab US, Inc.
- CanadaEPKINLYABBVIE CORPORATION
- SwitzerlandTepkinly 4 mg/0,8 ml, InjektionslösungAbbVie AG
- CzechiaTEPKINLYAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- SpainTEPKINLY 4 MG/0,8 ML SOLUCION INYECTABLEAbbvie Deutschland Gmbh & Co. Kg
- FinlandTepkinlyAbbVie Deutschland GmbH&Co.KG
- FranceTEPKINLY 4 mg/0,8 mL, solution injectableABBVIE DEUTSCHLAND (ALLEMAGNE)
- BelgiumTepkinly 4 mg/0.8 mlAbbVie Deutschland
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tepkinly
- Liechtenstein · Tepkinly
- Norway · Tepkinly
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd160f76-dcfd-4eb8-80b6-fbc29f5489da GET /v1/drugs/dd160f76-dcfd-4eb8-80b6-fbc29f5489da?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "42575411000001106",
"desc": "Tepkinly 4mg/0.8 ml concentrate for solution for injection vials (AbbVie Ltd)",
"form": "Solution for injection",
"vpid": "42578011000001105",
"source": "dmd",
"vtm_id": "42577111000001105",
"strength": "5 mg",
"substance": "Epcoritamab",
"ingredient": "Epcoritamab",
"supplier_code": "20741511000001103"
}See everything about epcoritamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.